NeuroMetrix, Inc.
NASDAQ Capital MarketTotal Valuation
NeuroMetrix, Inc. carries a market capitalization of 9.43M, placing it among publicly traded companies globally. Its enterprise value stands at -5.26M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 9.43M |
| Enterprise Value | -5.26M |
Share Statistics
NeuroMetrix, Inc. currently has 2.05M shares outstanding.
| Shares Outstanding | 2.05M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 2.55, and the price-to-book ratio stands at -0.04.
| PE Ratio | N/A |
| PS Ratio | 2.55 |
| PB Ratio | -0.04 |
| P/TBV Ratio | 0.54 |
| P/FCF Ratio | -1.08 |
| P/OCF Ratio | -1.08 |
Financial Position
NeuroMetrix, Inc. maintains a current ratio of 14.83, meaning it holds 14.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 14.83 |
| Quick Ratio | 13.12 |
| Debt / Equity | 0.75 |
| Debt / EBITDA | -0.01 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -42.48 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.93 |
Stock Price Statistics
NeuroMetrix, Inc.'s stock has gained approximately 19.58225% over the past 52 weeks. The 50-day moving average sits at 4.39, while the 200-day moving average is 4.01.
| Beta (5Y) | N/A |
| 52-Week Price Change | 19.58225% |
| 50-Day Moving Average | 4.39 |
| 200-Day Moving Average | 4.01 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, NeuroMetrix, Inc. generated 3.03M in revenue and converted that into -7.81M in net income, yielding earnings per share of -4.01. EBITDA reached -8.55M, while operating income came in at -8.78M.
| Revenue | 3.03M |
| Gross Profit | 1.68M |
| Operating Income | -8.78M |
| Pretax Income | -7.81M |
| Net Income | -7.81M |
| EBITDA | -8.55M |
| EBIT | -8.78M |
| Earnings Per Share (EPS) | -4.01 |
Balance Sheet
NeuroMetrix, Inc. holds 13.10M in cash and equivalents against 107,352.00 in total debt, resulting in a net debt position of -1.43M. Total book value stands at -217.92M, with working capital of 14.00M providing operational flexibility.
| Cash & Cash Equivalents | 13.10M |
| Total Debt | 107,352.00 |
| Net Debt | -1.43M |
| Equity (Book Value) | -217.92M |
| Book Value Per Share | -112.00 |
| Working Capital | 14.00M |
Cash Flow
NeuroMetrix, Inc. produced -7.13M in operating cash flow over the past twelve months.
| Operating Cash Flow | -7.13M |
| Capital Expenditures | N/A |
| Free Cash Flow | -7.13M |
| FCF Per Share | -3.66 |
Margins
NeuroMetrix, Inc. operates with a gross margin of 55.38, reflecting its pricing power and cost economics. The operating margin of -289.57 and net profit margin of -257.38 provide insight into operational efficiency.
| Gross Margin | 55.38 |
| Operating Margin | -289.57 |
| Pretax Margin | -257.38 |
| Profit Margin | -257.38 |
| EBITDA Margin | -281.88 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -19.11 |
| FCF Yield | -92.28 |
Stock Splits
NeuroMetrix, Inc.'s most recent stock split took place on November 22, 2023 with a 8:1 split ratio.
| Last Split Date | 11/22/2023 |
| Split Ratio | 8:1 |
Scores
NeuroMetrix, Inc. posts an Altman Z-Score of -15.93, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -15.93 |